Results revealed that ZnO nanoparticles to be effective against DN by increasing Nrf2-DNA-binding activity and downregulating thioredoxin-interacting protein (TXNIP) gene expression, which leads to oxidative stress suppression, and impairing inflammatory response by reducing NLRP3 inflammasome activation. This evidence concerns the gene TXNIP and liver dysplastic nodule.